ARCHIVES

Gleevec Approved For Pediatric CML

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004

BSA Approves 3 Concepts For Grants Worth $44 Million.

November 30, 2001

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

May 23, 1980

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

In Brief: GAO Reopens Clinical Center Controversy On Patient Care Payment; NIH Still Resists

January 6, 1978